The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
132 jobs Number of planned job losses
Announcement Date
3 April 2008
Employment effect (start)
6 April 2008
Foreseen end date
31 December 2011
Description
132 employees at the pharmaceutical company AstraZeneca Spain will lose their jobs as part of a restructuring process. The announcement was made on 3 April 2008 by the company management to its board and employees. Although the jobs cuts will be made in all areas, they will especially affect the sales department. The restructuring is part of AstraZeneca global plan and the company is expected to cut about 3000 jobs worldwide in the next three years.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
